FDA rules Avandia drug injuries not reason enough to remove from market

by fpw | July 22nd, 2010

July 22, 2010

With all the controversy about Avandia drug injuries and recalls, the FDA’s ruling on the drug may come as a surprise to some.

According to HealthDay News, after a trial of Avandia and the charges about the drug’s increased risk for heart disease, the FDA panel voted to keep the drug on the market.

However, the FDA did agree that the drug should receive new packaging, warning patients of the risk for Avandia drug injuries.
The drug came under fire when patients reported heart disease, stroke, and heart attacks associated with use of Avandia.

Read more.

Are you surprised about the FDA’s decision not to remove Avandia from the market?

Have you taken Avandia? Have you ever suffered Avandia drug injuries or drug injuries associated with other prescription drugs? Tell the Avandia lawyers at Ferrer,Poirot & Wansbrough about it. Let them help you.